MARKET

PASG

PASG

Passage Bio, Inc.
NASDAQ
0.4760
+0.0110
+2.37%
Closed 16:00 03/20 EDT
OPEN
0.4500
PREV CLOSE
0.4650
HIGH
0.4770
LOW
0.4300
VOLUME
45.88K
TURNOVER
--
52 WEEK HIGH
1.690
52 WEEK LOW
0.3520
MARKET CAP
29.58M
P/E (TTM)
-0.4439
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 2d ago
Weekly Report: what happened at PASG last week (0310-0314)?
Weekly Report · 4d ago
Weekly Report: what happened at PASG last week (0303-0307)?
Weekly Report · 03/10 09:16
Passage Bio (PASG) Upgraded to Buy: Here's What You Should Know
NASDAQ · 03/07 17:00
Analysts Offer Insights on Healthcare Companies: Ventyx Biosciences (VTYX), Black Diamond Therapeutics (BDTX) and Passage Bio (PASG)
TipRanks · 03/07 06:50
U.S. RESEARCH ROUNDUP-Accolade, CrowdStrike, Marriott International
Reuters · 03/05 07:53
PASSAGE BIO INC <PASG.O>: CHARDAN CAPITAL MARKETS CUTS TARGET PRICE TO $6 FROM $7
Reuters · 03/05 04:50
Passage Bio Advances Gene Therapy for Neurodegenerative Diseases
TipRanks · 03/05 04:02
More
About PASG
Passage Bio, Inc. is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Its lead clinical product candidate, PBFT02, seeks to elevate progranulin levels to enhance lysosomal function and slow disease progression across a variety of neurodegenerative diseases. PBFT02 utilizes an adeno-associated virus serotype 1, or AAV1, capsid to deliver a functional granulin gene, encoding progranulin (PGRN), to the brain via intra cisterna magna (ICM) administration. Its development programs consist of PBFT02 for the treatment of FTD-GRN, PBFT02 for the treatment of FTD-C9orf72 and amyotrophic lateral sclerosis, and PBFT02 for the treatment of Alzheimer’s disease. Its clinical product candidates include PBGM01, PBKR03 and PBML04. It has one unnamed preclinical research program that explores multiple potential treatment targets for Huntington's disease.

Webull offers Passage Bio Inc stock information, including NASDAQ: PASG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PASG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PASG stock methods without spending real money on the virtual paper trading platform.